PMVP - PMV Pharmaceuticals, Inc

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.4 -0.07 (-5.0%) 0.0 (0.0%) 0.0 (0.0%) 0.0 (-0.37%) 0.01 (0.69%) 0.0 (0.0%) 0.0 (0.0%) 0.11 (8.44%)

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.41
Diluted EPS:
-0.41
Basic P/E:
-3.2439
Diluted P/E:
-3.2439
RSI(14) 1m:
0.0
VWAP:
1.33
RVol:

Events

Period Kind Movement Occurred At

Related News